Skip to main content

The Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study: design, methods, and baseline characteristics.

Publication ,  Journal Article
Neighbors, CE; Wu, AE; Wixted, DG; Heidenfelder, BL; Kingsbury, CA; Register, HM; Louzao, R; Sloane, R; Eckstrand, J; Pieper, CC; Faldowski, RA ...
Published in: American journal of translational research
January 2022

Coronavirus Disease 2019 (COVID-19) is a viral illness with public health importance. The Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study is a prospective, longitudinal cohort study designed to contribute valuable information on community prevalence of active COVID-19 infection and SARS-CoV-2 antibodies as the pandemic and responses to it have and continue to evolve. We present the rationale, study design, and baseline characteristics of the C3PI Study.We recruited 1,426 participants between June 2020 and August 2020 from the Measurement to Understand the Reclassification of Disease of Cabarrus/Kannapolis (MURDOCK) Study Community Registry and Biorepository, a previously established, community-based, longitudinal cohort. Participants completed a baseline survey and follow-up surveys every two weeks. A nested weighted, random sub-cohort (n=300) was recruited to measure the incidence and prevalence of active COVID-19 infection and SARS-CoV-2 IgG antibodies.The sub-cohort was younger (56 vs 61 years), had more men (39.0% vs 30.9%), and a higher proportion of Hispanic (11.0% vs 5.1%) and Black participants (17.0% vs 8.2%) compared with the overall cohort. They had similar anthropometrics and medical histories, but a greater proportion of the sub-cohort had a higher educational degree (36.1% vs 31.3%) and reported a pre-pandemic annual household income of >$90,000 (57.1% vs 47.9%).This study is part of a multisite consortium that will provide critical data on the epidemiology of COVID-19 and community perspectives about the pandemic, behaviors and mitigation strategies, and individual and community burden in North Carolina.

Duke Scholars

Published In

American journal of translational research

EISSN

1943-8141

ISSN

1943-8141

Publication Date

January 2022

Volume

14

Issue

8

Start / End Page

5693 / 5711

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 3209 Neurosciences
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Neighbors, C. E., Wu, A. E., Wixted, D. G., Heidenfelder, B. L., Kingsbury, C. A., Register, H. M., … Newby, L. K. (2022). The Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study: design, methods, and baseline characteristics. American Journal of Translational Research, 14(8), 5693–5711.
Neighbors, Coralei E., Angie E. Wu, Douglas G. Wixted, Brooke L. Heidenfelder, Carla A. Kingsbury, Heidi M. Register, Raul Louzao, et al. “The Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study: design, methods, and baseline characteristics.American Journal of Translational Research 14, no. 8 (January 2022): 5693–5711.
Neighbors CE, Wu AE, Wixted DG, Heidenfelder BL, Kingsbury CA, Register HM, et al. The Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study: design, methods, and baseline characteristics. American journal of translational research. 2022 Jan;14(8):5693–711.
Neighbors, Coralei E., et al. “The Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study: design, methods, and baseline characteristics.American Journal of Translational Research, vol. 14, no. 8, Jan. 2022, pp. 5693–711.
Neighbors CE, Wu AE, Wixted DG, Heidenfelder BL, Kingsbury CA, Register HM, Louzao R, Sloane R, Eckstrand J, Pieper CC, Faldowski RA, Denny TN, Woods CW, Newby LK. The Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study: design, methods, and baseline characteristics. American journal of translational research. 2022 Jan;14(8):5693–5711.

Published In

American journal of translational research

EISSN

1943-8141

ISSN

1943-8141

Publication Date

January 2022

Volume

14

Issue

8

Start / End Page

5693 / 5711

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 3209 Neurosciences
  • 3202 Clinical sciences